Lam Research Corp
(LRCX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,194,719 | 5,086,544 | 4,042,151 | 4,418,263 | 3,673,366 |
| Marketable Securities | 160,072 | 242,590 | 569,472 | 1,310,872 | 2,116,101 |
| Receivables | 3,702,320 | 3,402,840 | 3,397,180 | 3,026,430 | 2,809,068 |
| Inventories | 3,479,332 | 3,074,177 | 2,872,141 | 2,689,294 | 2,552,032 |
| Other current assets | -1 | -2 | -2 | 3 | 0 |
| TOTAL | $11,888,100 | $12,102,860 | $11,144,680 | $11,652,390 | $11,322,270 |
| Non-Current Assets | |||||
| PPE Net | 1,561,875 | 1,503,385 | 1,372,533 | 1,303,479 | 1,279,836 |
| Intangibles | 1,627,035 | 1,601,755 | 1,614,959 | 1,622,499 | 1,633,254 |
| Other Non-Current Assets | 1,512,020 | 1,477,426 | 1,433,378 | 1,313,787 | 1,049,553 |
| TOTAL | $4,700,930 | $4,582,566 | $4,420,870 | $4,239,765 | $3,962,643 |
| Total Assets | $16,589,030 | $16,685,430 | $15,565,550 | $15,892,150 | $15,284,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,689 | 6,201 | 6,368 | 11,349 | 825,434 |
| Accounts payable and accrued liabilities | 1,007,026 | 952,666 | 837,708 | 829,710 | 760,942 |
| Accrued Expenses | 1,634,917 | 1,770,406 | 1,633,729 | 1,719,483 | 1,292,174 |
| TOTAL | $4,194,741 | $3,863,151 | $3,409,220 | $3,527,867 | $3,612,333 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,000,657 | 4,988,121 | 4,988,964 | 4,990,333 | 4,991,613 |
| Deferred Revenues | 1,545,109 | 1,133,878 | 931,415 | 967,325 | 733,783 |
| Other Non-Current Liabilities | 1,367,143 | 1,358,375 | 1,347,325 | 1,346,764 | 1,306,134 |
| TOTAL | $6,367,800 | $6,346,496 | $6,336,289 | $6,337,097 | $6,297,747 |
| Total Liabilities | $10,562,540 | $10,209,650 | $9,745,509 | $9,864,964 | $9,910,080 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,387,150 | 1,395,001 | 1,407,987 | 1,419,537 | 1,426,193 |
| Common Shares | 139 | 140 | 141 | 143 | 143 |
| Retained earnings | 17,451,400 | 16,637,680 | 15,653,440 | 14,684,910 | 13,725,680 |
| Other shareholders' equity | -97,442 | -88,398 | -81,341 | -63,827 | -60,013 |
| TOTAL | $6,026,490 | $6,475,781 | $5,820,043 | $6,027,188 | $5,374,833 |
| Total Liabilities And Equity | $16,589,030 | $16,685,431 | $15,565,552 | $15,892,152 | $15,284,913 |